Amgen, Inc. recalls AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial,
See all recalls from Amgen, Inc. →Recalled Product
AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01
Hazard / Issue
Lack of Assurance of Sterility: Potential cracks in glass vials
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: Lot #1071559, 1071629; Exp. 05/18
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for AMGEN Kyprolis (carfilzomib) for →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime